Bhisaj Pharma

Pharmaceutical research, development, and manufacturing of APIs and intermediates.

About Bhisaj Pharma

Bhisaj Pharma is a Healthcare company. Pharmaceutical research, development, and manufacturing of APIs and intermediates. It operates in the Healthcare and Chemicals & Materials sectors. Its Indian entity Bhisaj Pharmaceuticals Private Limited reported revenue of β‚Ή9.00 Cr. Bhisaj Pharma offers products and services including APIs and Intermediates. Its focus areas include Pharmaceuticals, API Manufacturing, Active Pharmaceutical Ingredients and Agriculture.

Company details

Bhisaj Pharma is recognized as a company that was incepted in 2018 and is engaged in manufacturing solutions for pharmaceutical companies, including active pharmaceutical ingredients, intermediates, and custom synthesis. It is noted for providing contract research and development services in areas like oncology and medicinal chemistry, while adhering to green chemistry principles. Strategic operations are maintained in the United States, Europe, and Japan, with a focus on quality products that meet regulatory requirements. Experienced scientists support RD efforts through alliances with institutions, ensuring timely delivery and innovation in processes.

  • Sectors
    Healthcare
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website bhisajpharma.com
  • Legal Name Bhisaj Pharmaceuticals Pvt Ltd
  • Date of Incorporation 09 Oct, 2018
  • Jurisdiction Pune, Maharashtra, India
Key Metrics
  • Indian entity revenue
    ₹9.00 Cr

    FY 2025 · +167% YoY

  • Indian entity net profit
    ₹51.1 Lakh

    FY 2025 · 6% margin

  • Indian entity EBITDA
    ₹82.5 Lakh

    FY 2025 · 9% margin

Products & Services of Bhisaj Pharma

Bhisaj Pharma offers a comprehensive portfolio of products and services, including APIs and Intermediates.

APIs
Pharmaceutical Products

Active pharmaceutical ingredients are manufactured and supplied for various drug segments, ensuring compliance with regulatory standards

Intermediates
Chemical Intermediates

Intermediates are developed and provided for antibiotics, anticancer, and other drugs, supporting pharmaceutical processes

Board of directors of Bhisaj Pharmaceuticals Private Limited (Bhisaj Pharma)

Bhisaj Pharmaceuticals Private Limited is the primary company behind Bhisaj Pharma. The board of Bhisaj Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Nilima Swapnil Sonawane, appointed in 2018. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Nilima Swapnil Sonawane
DIN 08252362
Director09 Oct 20188 yrsBhisaj Pharmaceuticals Private Limited
Sagar Nehate
DIN 08890486
Director23 Sep 20206 yrs 1 moBhisaj Pharmaceuticals Private Limited
Swapnil Panditrao Sonawane
DIN 07787008
Director10 Mar 20215 yrs 7 moBhisaj Pharmaceuticals Private Limited

Financials of Bhisaj Pharma

Figures of Bhisaj Pharmaceuticals Private Limited, the primary company behind Bhisaj Pharma, for FY 2025. Revenue was ₹9.00 Cr (+167% year on year). Net profit was ₹51.1 Lakh (6% margin). EBITDA was ₹82.5 Lakh (9% margin). Revenue has grown at a compounded annual rate of +80% over three years.

  • ₹9.00 CrRevenue · FY 2025 · +167% YoY
  • ₹51.1 LakhNet profit · 6% margin
  • ₹82.5 LakhEBITDA · 9% margin
  • ₹1 LakhPaid-up capital
  • +80%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Bhisaj Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Bhisaj Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bhisaj Pharma

The primary company behind Bhisaj Pharma, Bhisaj Pharmaceuticals Private Limited, reported revenue of β‚Ή9.00 Cr for FY 2025, up 167% year on year.

Bhisaj Pharma is recognized as a company that was incepted in 2018 and is engaged in manufacturing solutions for pharmaceutical companies, including active pharmaceutical ingredients, intermediates, and custom synthesis. It is noted for providing contract research and development services in areas like oncology and medicinal chemistry, while adhering to green chemistry principles. Strategic operations are maintained in the United States, Europe, and Japan, with a focus on quality products that meet regulatory requirements. Experienced scientists support RD efforts through alliances with institutions, ensuring timely delivery and innovation in processes.

Bhisaj Pharma offers APIs and Intermediates.

Bhisaj Pharma operates through Bhisaj Pharmaceuticals Private Limited.

The legal entities of Bhisaj Pharma currently have 3 directors, including Nilima Swapnil Sonawane, Sagar Nehate, Swapnil Panditrao Sonawane.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available